Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Platinum Group Metals | PLG | 5. nov 2024 | 1.75 | +1.16 |
Playa Hotels & Resorts | PLYA | 5. nov 2024 | 8.64 | +0.12 |
PlayAGS | AGS | 5. nov 2024 | 11.66 | +0.09 |
PLAYSTUDIOS A | MYPS | 5. nov 2024 | 1.46 | +5.80 |
Playtika Holding | PLTK | 5. nov 2024 | 8.05 | +1.90 |
PLBY Group | PLBY | 5. nov 2024 | 1.21 | -2.42 |
PLDT ADR | PHI | 5. nov 2024 | 23.82 | +0.63 |
Plexus | PLXS | 5. nov 2024 | 151.62 | +2.38 |
Pliant Therapeutics | PLRX | 5. nov 2024 | 14.90 | +2.83 |
Plug Power | PLUG | 5. nov 2024 | 2.52 | +0.40 |
Plum Acquisition I Units | PLMIU | 5. nov 2024 | 10.89 | 0.00 |
Plum Acquisition III A | PLMJ | 5. nov 2024 | 11.05 | 0.00 |
Plum Acquisition III Unit | PLMJU | 5. nov 2024 | 11.00 | -0.99 |
Plumas Bancorp | PLBC | 5. nov 2024 | 42.40 | +1.41 |
Pluri | PLUR | 5. nov 2024 | 4.69 | +2.85 |
Plus Therapeutics | PSTV | 5. nov 2024 | 1.36 | -0.01 |
Plymouth Industrial Reit | PLYM | 5. nov 2024 | 20.30 | +0.54 |
PMV Pharmaceuticals | PMVP | 5. nov 2024 | 1.65 | +0.61 |
PNC Financial Services Group | PNC | 5. nov 2024 | 188.80 | +1.53 |
PodcastOne | PODC | 5. nov 2024 | 1.32 | -2.22 |
POET Technologies | POET | 5. nov 2024 | 3.64 | +1.11 |
Poland Investable Mkt Index MSCI Ishares | EPOL | 5. nov 2024 | 22.58 | +0.40 |
Polar Power | POLA | 5. nov 2024 | 0.44 | -3.05 |
Polaris | PII | 5. nov 2024 | 71.33 | +0.69 |
Polestar ADR | PSNY | 5. nov 2024 | 1.28 | +4.92 |
PolyPid | PYPD | 5. nov 2024 | 3.34 | +0.23 |
Ponce Financial Group | PDLB | 5. nov 2024 | 11.95 | +3.02 |
Pool | POOL | 5. nov 2024 | 369.29 | +2.55 |
Pop Culture Group A | CPOP | 5. nov 2024 | 1.19 | 0.00 |
Popular | BPOP | 5. nov 2024 | 89.92 | +0.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.